Finance

Lists
GRCE:NASDAQ
Grace Therapeutics, Inc
$2.15
+1.90%
(+0.040) 1D
Sep 30, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GRCE...
Open
$2.14
High
$2.16
Low
$2.10
Mkt. cap
45.23M
Avg. vol.
130.81K
Volume
0.00
52-wk high
$5.18
52-wk low
$1.79
EPS
-$1.18
Beta
0.44
Shares outstanding
21.04M
No. of employees
5
Open
$2.14
High
$2.16
Low
$2.10
Mkt. cap
45.23M
Avg. vol.
130.81K
Volume
0.00
52-wk high
$5.18
52-wk low
$1.79
EPS
-$1.18
Beta
0.44
Shares outstanding
21.04M
No. of employees
5
News stories
From web sources and news partners
About Grace Therapeutics, Inc
CEO-
Employees5
Founded2002
Headquarters-
SectorPharmaceutical industry
Websitegracetx.com
Analyst ratings
Based on 1 analyst giving stock ratings to GRCE in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for GRCE in the last 3 months
Highest
Current $2.15
$4.00 (+86.05%)
Average
$4.00 (+86.05%)
Lowest
$4.00 (+86.05%)
Analyst
Recommendation
Action
Price target
Projected
Date
Chase Knickerbocker
Craig-Hallum
Buy
Reiterated
$4.00
+86%
08/18/2026
Stacy Ku
TD Cowen
Buy
Reiterated
$8.00
+272.1%
04/23/2026
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
568.00K
462.00K
420.00K
697.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.96M
1.99M
2.59M
1.69M
Operating expense
2.53M
2.45M
3.01M
2.38M
Total operating expenses
2.53M
2.45M
3.01M
2.38M
Operating income
-2.53M
-2.45M
-3.01M
-2.38M
Other non operating income
1.43M
-42.00K
-
-
EBT including unusual items
-938.00K
-2.32M
-2.88M
-15.79M
EBT excluding unusual items
-938.00K
-2.32M
-2.88M
-2.26M
Income tax expense
-
-
-1.70M
-
Effective tax rate
-
-
59.07%
-
Other operating expenses
-
-
-
-
Net income
-938.00K
-2.32M
-1.18M
-15.79M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
172.00K
172.00K
138.00K
141.00K
Interest expense
-
-
-
-
Net interest expenses
172.00K
172.00K
138.00K
141.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.53M
-2.45M
-3.01M
-2.38M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps